Airway Management Devices Market Size to Surpass US$4.2 Billion by 2027
The global Airway Management Devices market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 4.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 4.9% during the prediction period 2021 to 2027. Increasing admissions across emergency & intensive care units, increasing prevalence of chronic respiratory diseases such as asthma and COPD, rise in geriatric population, growing investments in healthcare infrastructure, favorable reimbursement coverage across developed countries, and the high incidence of pre-term births are driving the significant revenue growth in the market. The adoption of single-use airway management devices have increased considerably, which is offering significant growth opportunities to the vendors. Moreover, rising demand for airway management devices across emerging countries, due to rise in surgical procedures is also presenting a significant growth opportunities for the vendors in the market.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Airway Management Devices market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Airway Management Devices market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Airway Management Devices market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America accounted for the largest share of the airway management devices market in 2020
In 2020, North America accounted for the largest share of the airway management devices market, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa. The large share of this market segment can be characterized by the presence of a highly developed healthcare system, the significant number of prominent vendors, the increasing number of healthcare settings, the rising prevalence of chronic respiratory diseases, and favorable reimbursement policies for airway management devices.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Airway Management Devices Market are:
The prominent players in this market are Medtronic plc (Ireland), Smiths Medical (UK), Teleflex Inc. (US), Ambu A/S (Denmark), Convatec Group plc (UK), KARL STORZ (Germany), Flexicare (US), Intersurgical Ltd. (UK), SunMed LLC (US), Vyaire Medical (US), VBM Medizintechnik (Germany), Verathon (US), SourceMark (US), Mercury Enterprises (US), TRACOE medical (Germany).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global Airway Management Devices Market, by Type
Global Airway Management Devices Market, by Application
Global Airway Management Devices Market, by Patient Age
Global Airway Management Devices Market, by End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Airway Management Devices Market, By Type
7.1. Airway Management Devices Market, by Type, 2021-2027
7.1.1. Infraglottic Airway Management Devices
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Infraglottic Airway Management Devices
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Laryngoscopes
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Resuscitators
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Cricothyrotomy Kits
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Other Airway Management Devices
7.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Airway Management Devices Market, By Application
8.1. Airway Management Devices Market, by Application, 2021-2027
8.1.1. Anesthesia
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Emergency Medicine
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Airway Management Devices Market, By Patient Age
9.1. Airway Management Devices Market, by Patient Age, 2021-2027
9.1.1. Others
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Pediatric/Neonatal Patients
9.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Airway Management Devices Market, By End User
10.1. Airway Management Devices Market, by End User, 2021-2027
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Ambulatory Care Settings
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Ambulatory Care Settings
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Airway Management Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2016-2027)
11.1.2. Market Revenue and Forecast, by Application (2016-2027)
11.1.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.1.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Type (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Type (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2016-2027)
11.2.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.2.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Type (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Type(2016-2027)
11.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Type (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Type (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2016-2027)
11.3.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.3.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Type (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Type (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Type (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Type (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2016-2027)
11.4.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.4.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Type (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Type (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Type (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Type (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2016-2027)
11.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.5.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Type (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Type (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Patient Age (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End User (2016-2027)
Chapter 12. Company Profiles
12.1. Medtronic plc (Ireland)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Smiths Medical (UK)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Teleflex Inc. (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Ambu A/S (Denmark)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Convatec Group plc (UK)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. KARL STORZ (Germany)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. KARL STORZ (Germany)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Intersurgical Ltd. (UK)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. SunMed LLC (US)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Term
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers